IDEXX Laboratories is trading lower today amid reports highlighting ongoing challenges within the U.S. veterinary market.
This pressure persists despite the company's recent announcement that it has acquired CoVetAI, a move marking the first exit for the Chicago Pacific Founders Pet Fund. While the broader veterinary diagnostics market is projected to grow to 30.78 billion dollars by 2035 at a 10.1 percent CAGR, the stock remains under mi